Publications by authors named "E Low"
Purpose: The primary aim of this retrospective study is to compare the short and medium-term outcomes for shoulder hydrodilatation for treatment of shoulder AC between diabetic and non-diabetic patients, to evaluate if there were better outcomes amongst non-diabetic patients.
Methods: Patients with clinical or radiological diagnosis of AC and who underwent fluoroscopic guided shoulder hydrodilatation in our local institution from January 2021 to June 2022 were included in this study. Clinical outcomes were measured with visual analog scale (VAS) for pain and passive range of motion consisting of forward flexion (FF) and external rotation (ER) at pre-hydrodilatation, one month and six months post hydrodilatation.
Objectives: The use of cost-effectiveness methods to support policy decisions has become well established, but difficulties can arise when evaluating a new treatment that is indicated to be used in combination with an established backbone treatment. If the latter has been priced close to the decision maker's willingness-to-pay threshold, this may mean that there is no headroom for the new treatment to demonstrate value, at any price, even if the combination is clinically effective. Without a mechanism for attributing value to component treatments within a combination therapy, the health system risks generating negative funding decisions for combinations of proven clinical benefit to patients.
View Article and Find Full Text PDFIntroduction And Importance: Mucinous tubular and spindle cell carcinoma (MTSCC) is a rare and usually slow-growing subtype of renal cell carcinoma (RCC), with low malignant potential. There is scant knowledge in the literature of this rare subtype of renal cell carcinoma.
Case Presentation: We present the case of a 56 year old with an aggressive recurrent metastatic MTSCC para-aortic lymph node treated with surgical excision.